GLUT1 deficiency syndrome
Jump to navigation
Jump to search
Pathology
- defect in glucose transport across the blood-brain barrier
Genetics
- autosomal dominant form associated with defects in SLC2A1 (GLUT1)
Clinical manifestations
- infantile seizures
- delayed development
- acquired microcephaly
Management
- triheptanoin (Dojolvi) used experimentally to treat GLUT1 deficiency syndrome